GSK-LSD1 is a selective LSD1 inhibitor with potential anticancer activity that attenuates the expression of CTGF/CCN2, MMP13, LOXL4, and waveform proteins in cancer cells.GSK-LSD1 regulates the cell cycle, induces apoptosis, and can be used to study breast cancer.
Molecular Weight:
216.32
Purity:
99.59%
CAS Number:
[1431368-48-7]
Formula:
C14H20N2
Target:
Histone Demethylase|||Apoptosis
T82254
* VAT and and shipping costs not included. Errors and price changes excepted